Student, University of Macau, Macao
Liyang Lyu, a PhD candidate at the University of Macau, specializes in pharmaceutical patent research, with a primary focus on cancer immunotherapy. She has authored two articles in Nature Biotechnology, focusing on the advancements in iPSC and CAR-T therapies.